Patents by Inventor Julie McEarchern

Julie McEarchern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
    Patent number: 7491390
    Abstract: Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunosuppressive without conjugation to a therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering to a subject the CD70-binding agent.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: February 17, 2009
    Assignee: Seattle Genetics, Inc.
    Inventors: Che-Leung Law, Julie McEarchern, Alan F. Wahl
  • ANTI-CD70 ANTIBODY AND ITS USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS
    Publication number: 20080138343
    Abstract: Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunosuppressive without conjugation to a therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering to a subject the CD70-binding agent.
    Type: Application
    Filed: January 18, 2008
    Publication date: June 12, 2008
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Che-Leung Law, Julie McEarchern, Alan F. Wahl
  • Anti-CD70 antibody and its use for the treatment of cancer and immune disorders
    Publication number: 20080138341
    Abstract: Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunosuppressive without conjugation to a therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering to a subject the CD70-binding agent.
    Type: Application
    Filed: January 18, 2008
    Publication date: June 12, 2008
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Che-Leung Law, Julie McEarchern, Alan F. Wahl
  • ANTI-CD70 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS
    Publication number: 20080025989
    Abstract: Disclosed are anti-CD70 antibodies and derivatives thereof conjugated to cytotoxic, immunosuppressive, or other therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody- and antibody derivative-drug conjugates. Also disclosed are methods, for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the disclosed pharmaceutical compositions.
    Type: Application
    Filed: April 13, 2007
    Publication date: January 31, 2008
    Applicant: Seattle Genetics, Inc.
    Inventors: Che-Leung Law, Julie McEarchern, Jonathan Drachman
  • ANTI-CD70 ANTIBODY AND ITS USE FOR THE TREATMENT AND PREVENTION OF CANCER AND IMMUNE DISORDERS
    Publication number: 20070292422
    Abstract: Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunomodulatory without conjugation to a therapeutic agents as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering the CD70 binding agents to a subject.
    Type: Application
    Filed: April 13, 2007
    Publication date: December 20, 2007
    Applicant: Seattle Genetics, Inc.
    Inventors: Che-Leung Law, Julie McEarchern, Alan Wahl
  • Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
    Publication number: 20060083736
    Abstract: Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunosuppressive without conjugation to a therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering to a subject the CD70-binding agent.
    Type: Application
    Filed: October 14, 2005
    Publication date: April 20, 2006
    Applicant: Seattle Genetics, Inc.
    Inventors: Che-Leung Law, Julie McEarchern, Alan Wahl
  • Tangential flow filtration devices and methods for stem cell enrichment
    Publication number: 20050189297
    Abstract: The present invention provides methods for enriching a heterogenous mixture of bone marrow or blood constituents for stem cells by removal of non-stem cell constituents comprising separation of the non-stem cell constituents using a tangential flow filtration device.
    Type: Application
    Filed: November 18, 2004
    Publication date: September 1, 2005
    Applicant: Northwest Biotherapeutics, Inc.
    Inventors: Marnix Bosch, Patricia Lodge, Julie McEarchern, Alton Boynton, Paul Hugenholtz